InvenireX

Seed
invenirex.co.uk Biotech & Healthcare
Total Funding $637K
Latest Round Undisclosed Seed
Last Announced Jan 7, 2026
Investors Undisclosed
Decision Makers Profile Active

About InvenireX

InvenireX is developing ultra-sensitive nucleic acid detection instrumentation for life sciences research.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Seed
Global Headquarters Undisclosed
Tracked Since Nov 6, 2026

Web & Domain Identity

Official Website invenirex.co.uk
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile @Invenirex (6 followers)
LinkedIn Corporate Company Profile

Company Milestones & Timeline

3 Events
  1. Capital Raise

    Raised undisclosed · Seed

    fundraisingfox.com

  2. Capital Raise

    Raised undisclosed · Seed

    fundraisingfox.com

  3. Capital Raise

    Raised $636,800 · Round

    news.google.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for InvenireX.

Funding History

3 Rounds
Seed equity · Jan 7, 2026
Seed equity · Nov 18, 2025
Round equity · Mar 18, 2024

Founders & Leadership

1

Dan Todd

Founder & CEO

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts